These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6539179)

  • 1. Plasma prolactin in women with mastodynia.
    Graziottin A; Sopracordevole F; Velasco M; Grella PV
    Clin Exp Obstet Gynecol; 1984; 11(3):113-6. PubMed ID: 6539179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal profile of benign breast disease and premenstrual mastodynia.
    Gorins A; Cordray JP
    Eur J Gynaecol Oncol; 1984; 5(1):1-10. PubMed ID: 6698047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.
    Walsh PV; McDicken IW; Bulbrook RD; Moore JW; Taylor WH; George WD
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1345-51. PubMed ID: 6542005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154).
    Schulz KD; Del Pozo E; Lose KH; Künzig HJ; Geiger W
    Arch Gynakol; 1975 Dec; 220(1):83-7. PubMed ID: 1243527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma prolactin and testosterone during the luteal phase in women with premenstrual tension syndrome.
    Bäckström T; Aakvaag A
    Psychoneuroendocrinology; 1981; 6(3):245-51. PubMed ID: 7197377
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolating with physical restraint low status female monkeys during luteal phase might make an appropriate premenstrual depression syndrome model.
    Qiao M; Zhao Q; Zhang H; Wang H; Xue L; Wei S
    J Affect Disord; 2007 Sep; 102(1-3):81-91. PubMed ID: 17258814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadequate luteal phase and benign breast disease.
    Marchesoni D; Gangemi M; Mozzanega B; Paternoster D; Graziottin A; Maggino T
    Clin Exp Obstet Gynecol; 1981; 8(4):160-3. PubMed ID: 7346187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics.
    Andersch B; Abrahamsson L; Wendestam C; Ohman R; Hahn L
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):657-64. PubMed ID: 575318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of the premenstrual syndrome and especially of cyclic mastodynia with bromocriptine].
    Hauser GA
    Ther Umsch; 1983 Jul; 40(7):604-9. PubMed ID: 6684802
    [No Abstract]   [Full Text] [Related]  

  • 10. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSH and prolactin responses to TRH in patients with premenstrual syndrome.
    Roy-Byrne PP; Rubinow DR; Hoban MC; Grover GN; Blank D
    Am J Psychiatry; 1987 Apr; 144(4):480-4. PubMed ID: 3105336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian hormone secretory profiles in women with severe premenstrual tension syndrome.
    Steiner M; Haskett RF; Carroll BJ; Hays SE; Rubin RT
    Br J Obstet Gynaecol; 1984 May; 91(5):466-71. PubMed ID: 6539122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prolactin and severe premenstrual tension.
    Steiner M; Haskett RF; Carroll BJ; Hays SE; Rubin RT
    Psychoneuroendocrinology; 1984; 9(1):29-35. PubMed ID: 6539925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "luteal breast": hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia.
    Ayers JW; Gidwani GP
    Fertil Steril; 1983 Dec; 40(6):779-84. PubMed ID: 6653797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin levels in the premenstrual syndrome.
    O'Brien PM; Symonds EM
    Br J Obstet Gynaecol; 1982 Apr; 89(4):306-8. PubMed ID: 7200371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
    Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
    Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
    [No Abstract]   [Full Text] [Related]  

  • 18. Benign breast disease I: hormonal investigation.
    Sitruk-Ware R; Sterkers N; Mauvais-Jarvis P
    Obstet Gynecol; 1979 Apr; 53(4):457-60. PubMed ID: 571588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials.
    van Die MD; Burger HG; Teede HJ; Bone KM
    Planta Med; 2013 May; 79(7):562-75. PubMed ID: 23136064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.
    Kwa HG; Wang DY
    Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.